Osong Public Health and Research Perspectives

From articles published in Osong Public Health and Research Perspectives during the past two years (2022 ~ ).

Review Articles

Yersinia pestis antibiotic resistance: a systematic review: Chen Lei, Suresh Kumar; Osong Public Health Res Perspect. 2022;13(1):24-36. Published online February 18, 2022; DOI: https://doi.org/10.24171/j.phrp.2021.0288

9,508 View
289 Download
12 Web of Science
15 Crossref

Yersinia pestis, the cause of plague and a potential biological weapon, has always been a threatening pathogen. Some strains of Y. pestis have varying degrees of antibiotic resistance. Thus, this systematic review was conducted to alert clinicians to this pathogen’s potential antimicrobial resistance. A review of the literature was conducted for experimental reports and systematic reviews on the topics of plague, Y. pestis, and antibiotic resistance. From 1995 to 2021, 7 Y. pestis isolates with 4 antibiotic resistance mechanisms were reported. In Y. pestis 17/95, 16/95, and 2180H, resistance was mediated by transferable plasmids. Each plasmid contained resistance genes encoded within specific transposons. Strain 17/95 presented multiple drug resistance, since plasmid 1202 contained 10 resistance determinants. Strains 16/95 and 2180H showed single antibiotic resistance because both additional plasmids in these strains carried only 1 antimicrobial determinant. Strains 12/87, S19960127, 56/13, and 59/13 exhibited streptomycin resistance due to an rpsl gene mutation, a novel mechanism that was discovered recently. Y. pestis can acquire antibiotic resistance in nature not only via conjugative transfer of antimicrobial-resistant plasmids from other bacteria, but also by gene point mutations. Global surveillance should be strengthened to identify antibiotic-resistant Y. pestis strains by whole-genome sequencing and drug susceptibility testing.

Citations

Citations to this article as recorded by

Seek and you shall find: Yersinia enterocolitica in Ireland’s drinking water
James Powell, Maureen Daly, Nuala H. O’Connell, Colum P. Dunne
Irish Journal of Medical Science (1971 -).2024; 193(4): 1885. CrossRef
A novel sORF gene mutant strain of Yersinia pestis vaccine EV76 offers enhanced safety and improved protection against plague
Xiao Guo, Youquan Xin, Zehui Tong, Shiyang Cao, Yuan Zhang, Gengshan Wu, Hongyan Chen, Tong Wang, Yajun Song, Qingwen Zhang, Ruifu Yang, Zongmin Du, Gregory P. Priebe
PLOS Pathogens.2024; 20(3): e1012129. CrossRef
Interaction between Yersinia pestis Ail Outer Membrane Protein and the C-Terminal Domain of Human Vitronectin
Laurine Vasseur, Florent Barbault, Antonio Monari
The Journal of Physical Chemistry B.2024; 128(16): 3929. CrossRef
Integrated Computational Analysis of Physicochemical Features, Biological Properties, Kinase Target Prediction and Biotransformation Pathways in Drug Discovery
Mohamed Sabri Bensaad, Dhiya Eddine Bensaad, Mohamed Amine Kahoul, Dania S. Waggas, Roua S. Baty, Rokayya Sami, Hamsa Jameel Banjer, Siraj B. Alharthi, Ruqaiah I. Bedaiwi, Zeyad M. Alharbi, Mohammad A. Alanazi, Nouf H. Alsubhi, Ashwaq M. Al-Nazawi, Nada A
International Journal of Pharmacology.2024; 20(5): 748. CrossRef
Emerging Microorganisms and Infectious Diseases: One Health Approach for Health Shared Vision
Maria Vittoria Ristori, Valerio Guarrasi, Paolo Soda, Nicola Petrosillo, Fiorella Gurrieri, Umile Giuseppe Longo, Massimo Ciccozzi, Elisabetta Riva, Silvia Angeletti
Genes.2024; 15(7): 908. CrossRef
Screening of promising molecules against potential drug targets in Yersinia pestis by integrative pan and subtractive genomics, docking and simulation approach
Lei Chen, Lihu Zhang, Yanping Li, Liang Qiao, Suresh Kumar
Archives of Microbiology.2024;[Epub] CrossRef
Plasmonic-Enhanced Colorimetric Lateral Flow Immunoassays Using Bimetallic Silver-Coated Gold Nanostars
Supriya Atta, Yuanhao Zhao, Sebastian Sanchez, Deven Seedial, Jasmine Pramila Devadhasan, Alexander Jarrett Summers, Marcellene A. Gates-Hollingsworth, Kathryn J Pflughoeft, Jian Gu, Douglas C. Montgomery, David P. AuCoin, Frederic Zenhausern, Tuan Vo-Din
ACS Applied Materials & Interfaces.2024;[Epub] CrossRef
Rapid Induction of Protective Immunity against Pneumonic Plague by Yersinia pestis Polymeric F1 and LcrV Antigens
Moshe Aftalion, Avital Tidhar, Yaron Vagima, David Gur, Ayelet Zauberman, Tzvi Holtzman, Arik Makovitzki, Theodor Chitlaru, Emanuelle Mamroud, Yinon Levy
Vaccines.2023; 11(3): 581. CrossRef
Antibiotic resistance in Neisseria gonorrhoeae: broad-spectrum drug target identification using subtractive genomics
Umairah Natasya Mohd Omeershffudin, Suresh Kumar
Genomics & Informatics.2023; 21(1): e5. CrossRef
Polyclonal Antibodies Derived from Transchromosomic Bovines Vaccinated with the Recombinant F1-V Vaccine Increase Bacterial Opsonization In Vitro and Protect Mice from Pneumonic Plague
Sergei S. Biryukov, Hua Wu, Jennifer L. Dankmeyer, Nathaniel O. Rill, Christopher P. Klimko, Kristi A. Egland, Jennifer L. Shoe, Melissa Hunter, David P. Fetterer, Ju Qiu, Michael L. Davies, Christoph L. Bausch, Eddie J. Sullivan, Thomas Luke, Christopher
Antibodies.2023; 12(2): 33. CrossRef
New Bacteriophages with Podoviridal Morphotypes Active against Yersinia pestis: Characterization and Application Potential
Tamar Suladze, Ekaterine Jaiani, Marina Darsavelidze, Maia Elizbarashvili, Olivier Gorge, Ia Kusradze, Tamar Kokashvili, Nino Lashkhi, George Tsertsvadze, Nino Janelidze, Svetlana Chubinidze, Marina Grdzelidze, Shota Tsanava, Eric Valade, Marina Tediashvi
Viruses.2023; 15(7): 1484. CrossRef
Characterization of Mu-Like Yersinia Phages Exhibiting Temperature Dependent Infection
Biao Meng, Zhizhen Qi, Xiang Li, Hong Peng, Shanzheng Bi, Xiao Wei, Yan Li, Qi Zhang, Xiaoqing Xu, Haihong Zhao, Xiaoyan Yang, Changjun Wang, Xiangna Zhao, Olaya Rendueles
Microbiology Spectrum.2023;[Epub] CrossRef
Ancient Yersinia pestis genomes lack the virulence-associated Ypf Φ prophage present in modern pandemic strains
Joanna H. Bonczarowska, Julian Susat, Ben Krause-Kyora, Dorthe Dangvard Pedersen, Jesper Boldsen, Lars Agersnap Larsen, Lone Seeberg, Almut Nebel, Daniel Unterweger
Proceedings of the Royal Society B: Biological Sci.2023;[Epub] CrossRef
A situation analysis of the current plague outbreak in the Demographic Republic of Congo and counteracting strategies – Correspondence
Ranjit Sah, Abdullah Reda, Rachana Mehta, Ranjan K. Mohapatra, Kuldeep Dhama
International Journal of Surgery.2022; 105: 106885. CrossRef
Antimicrobial resistance in Klebsiella pneumoniae: identification of bacterial DNA adenine methyltransferase as a novel drug target from hypothetical proteins using subtractive genomics
Umairah Natasya Mohd Omeershffudin, Suresh Kumar
Genomics & Informatics.2022; 20(4): e47. CrossRef

India’s efforts to achieve 1.5 billion COVID-19 vaccinations: a narrative review: Kapil Singh, Ashwani Verma, Monisha Lakshminarayan; Osong Public Health Res Perspect. 2022;13(5):316-327. Published online October 14, 2022; DOI: https://doi.org/10.24171/j.phrp.2022.0104

5,537 View
108 Download
9 Web of Science
13 Crossref

Graphical Abstract Abstract PDF

The initial case of coronavirus disease 2019 (COVID-19) in India was reported on January 30, 2020, and subsequently, the number of COVID-19-infected patients surged during the first wave of April 2020 and the second wave in the same month of 2021. The government of India imposed a strict nationwide lockdown in April 2020 and extended it until May 2020. The second wave of COVID-19 in India overwhelmed the country’s health facilities and exhausted its medical and paramedical workforce. This narrative review was conducted with the aim of summarizing the evidence drawn from policy documents of governmental and non-governmental organizations, as well as capturing India's COVID-19 vaccination efforts. The findings from this review cover the Indian government's vaccination initiatives, which ranged from steps taken to combat vaccine hesitancy to vaccination roadmaps, deployment plans, the use of digital health technology, vaccination monitoring, adverse effects, and innovative strategies such as Har Ghar Dastak and Jan Bhagidari Andolan (people’s participation). These efforts collectively culminated in the successful administration of more than 1.8 billion doses of COVID-19 vaccines in India. This review also provides insights into other countries’ responses to COVID-19 and guidance for future pandemics.

Citations

Citations to this article as recorded by

Developments and Trends of Immunization in India: A Narrative Review
Pratik P Tawde, Zahiruddin Quazi, Abhay Gaidhane, Sonali G Choudhari
Cureus.2024;[Epub] CrossRef
Digital health technology used in emergency large-scale vaccination campaigns in low- and middle-income countries: a narrative review for improved pandemic preparedness
Paula Mc Kenna, Lindsay A. Broadfield, Annik Willems, Serge Masyn, Theresa Pattery, Ruxandra Draghia-Akli
Expert Review of Vaccines.2023; 22(1): 243. CrossRef
Media Reporting Relating to COVID-19 Vaccination as a Driver of Vaccine Hesitancy Prior to the Second Wave of the COVID-19 Pandemic in India: A Content Analysis of Newspaper and Digital Media Reports
Saurav Basu, Himanshi Sharma
Cureus.2023;[Epub] CrossRef
An assessment of the strategy and status of COVID-19 vaccination in India
Sneh Lata Gupta, Surbhi Goswami, Ananya Anand, Namrata Naman, Priya Kumari, Priyanka Sharma, Rishi K. Jaiswal
Immunologic Research.2023; 71(4): 565. CrossRef
Development of a Choice-framework for Covid vaccines in India using a multi-criteria decision analysis approach
Tarun K. George, Nayana P. Nair, Awnish Kumar Singh, A. Dilesh Kumar, Arup Deb Roy, Varshini Neethi Mohan, Gagandeep Kang
Vaccine.2023; 41(25): 3755. CrossRef
COVID-19 Booster Dose Coverage and Hesitancy among Older Adults in an Urban Slum and Resettlement Colony in Delhi, India
Nandini Sharma, Saurav Basu, Heena Lalwani, Shivani Rao, Mansi Malik, Sandeep Garg, Rahul Shrivastava, Mongjam Meghachandra Singh
Vaccines.2023; 11(7): 1177. CrossRef
Review of the unmet medical need for vaccination in adults with immunocompromising conditions: An Indian perspective
Ashok Vaid, Neha Rastogi, T. Mark Doherty, Peter San Martin, Yashpal Chugh
Human Vaccines & Immunotherapeutics.2023;[Epub] CrossRef
Translating the COVID-19 experience in widening the HPV vaccination campaign for cervical cancer in India
Aruni Ghose, Anisha Agarwal, Bhawna Sirohi, Shona Nag, Linus Chuang, Swarupa Mitra
Gynecologic Oncology Reports.2023; 48: 101247. CrossRef
Symptomatic prevalence of covid-19 in vaccinated and non-vaccinated population
Jay Bhupesh Pandya, Nirali Milind Shethia, Divya Bangera, Shailaja Gada Saxena
IP International Journal of Medical Microbiology a.2023; 9(2): 110. CrossRef
Active surveillance of adverse events following COVID-19 vaccines in a tertiary care hospital
Naveena Mary Cherian, Dravya Anna Durai, Muhammed Jaisel, Divyansh Sharma, Juny Sebastian, Chetak Kadabasal Basavaraja, Merrin Mathew
Therapeutic Advances in Vaccines and Immunotherapy.2023;[Epub] CrossRef
Effectiveness of ayurvedic formulation, NAOQ19 along with standard care in the treatment of mild-moderate COVID-19 patients: A double blind, randomized, placebo-controlled, multicentric trial
Pankaj Bhardwaj, Kalaiselvan Ganapathy, Monika Pathania, K.H. Naveen, Jaykaran Charan, Siddhartha Dutta, Ravisekhar Gadepalli, Srikanth Srinivasan, Manoj Kumar Gupta, Akhil D. Goel, Naresh Midha, Bharat Kumar, Meenakshi Sharma, Praveen Sharma, Mithu Baner
Journal of Ayurveda and Integrative Medicine.2023; 14(6): 100778. CrossRef
Balancing Routine and Pandemic: The Synergy of India’s Universal Immunization Program and COVID-19 Vaccination Program
Pawan Kumar, Ashish Birendra Chakraborty, Suhas Dhandore, Pritu Dhalaria, Ajeet Kumar Singh, Disha Agarwal, Kapil Singh, Pretty Priyadarshini, Paras Jain, Vidushi Bahl, Gunjan Taneja
Vaccines.2023; 11(12): 1776. CrossRef
Unveiling vaccine safety: a narrative review of pharmacovigilance in India's COVID-19 vaccination
Megha Hegde, Saurav Raj, Dhananjay Tikadar, Sanatkumar B Nyamagoud
Monaldi Archives for Chest Disease.2023;[Epub] CrossRef

Brief Reports

The effectiveness of Paxlovid treatment in long-term care facilities in South Korea during the outbreak of the Omicron variant of SARS-CoV-2: Hanul Park, Young Joon Park, Hye Young Lee, Mi Yu, Yeong-Jun Song, Sang Eun Lee, Ji-Joo Lee, Eun-Sol Lee, Yeonjung Kim; Osong Public Health Res Perspect. 2022;13(6):443-447. Published online December 23, 2022; DOI: https://doi.org/10.24171/j.phrp.2022.0262

4,720 View
230 Download
9 Web of Science
12 Crossref

Graphical Abstract Abstract PDF

Objectives
On November 5, 2021, Pfizer Inc. announced Paxlovid (nirmatrelvir +ritonavir) asa treatment method that could reduce the risk of hospitalization or death for patients withconfirmed coronavirus disease 2019 (COVID-19).Methods: From February 6, 2022 to April 2, 2022, the incidence of COVID-19 and the effectsof treatment with Paxlovid were analyzed in 2,241 patients and workers at 5 long-term carefacilities during the outbreak of the Omicron variant of severe acute respiratory syndromecoronavirus 2 in South Korea.Results: The rate of severe illness or death in the group given Paxlovid was 51% lower thanthat of the non-Paxlovid group (adjusted risk ratio [aRR], 0.49; 95% confidence interval [CI],0.24−0.98). Compared to unvaccinated patients, patients who had completed 3 doses of thevaccine had a 71% reduced rate of severe illness or death (aRR, 0.29; 95% CI, 0.13−0.64) and a65% reduced death rate (aRR, 0.35; 95% CI, 0.15−0.79).Conclusion: Patients given Paxlovid showed a lower rate of severe illness or death and alower fatality rate than those who did not receive Paxlovid. Patients who received 3 dosesof the vaccine had a lower rate of severe illness or death and a lower fatality rate than theunvaccinated group.

Citations

Citations to this article as recorded by

Efficacy and safety of antiviral treatments for symptomatic COVID-19 outpatients: Systematic review and network meta-analysis
Meital Zur, Thalia Peselev, Stav Yanko, Victoria Rotshild, Ilan Matok
Antiviral Research.2024; 221: 105768. CrossRef
Clinical Effectiveness of Ritonavir-Boosted Nirmatrelvir—A Literature Review
Sydney Paltra, Tim O. F. Conrad
Advances in Respiratory Medicine.2024; 92(1): 66. CrossRef
Effectiveness of nirmatrelvir‐ritonavir on severe outcomes of COVID‐19 in the era of vaccination and Omicron: An updated meta‐analysis
Sien Ombelet, Diego Castanares‐Zapatero, Fabian Desimpel, Frank Hulstaert, Sabine Stordeur, Dominique Roberfroid
Journal of Medical Virology.2024;[Epub] CrossRef
Epidemiological evolution and economic impact of the COVID-19 pandemic in the European Union and worldwide and effects of control strategies on them: An ecological study
J.A. Caylà, J.M. Bellmunt, J.M. Jansà, A. Marco, J.P. Millet
Medicina de Familia. SEMERGEN.2024; 50(6): 102274. CrossRef
Clinical real-world effectiveness of nirmatrelvir/ritonavir for the treatment of SARS-CoV-2 infection: A meta-analysis
Chienhsiu Huang, Sufang Kuo, Lichen Lin
Tungs' Medical Journal.2024; 18(Suppl 1): S35. CrossRef
Comparing the effectiveness of molnupiravir and nirmatrelvir‐ritonavir in non‐hospitalized and hospitalized COVID‐19 patients with type 2 diabetes: A target trial emulation study
Eric Y. F. Wan, Zoey C. T. Wong, Vincent K. C. Yan, Celine S. L. Chui, Francisco T. T. Lai, Xue Li, Ian C. K. Wong, Esther W. Y. Chan
Diabetes, Obesity and Metabolism.2024; 26(10): 4653. CrossRef
COVID‐19 infection in patients with haematological malignancies: A single‐centre survey in the latest Omicron wave in China
Xiaolu Zhu, Qian Jiang, Jin Lu, Yuqian Sun, Xiaosu Zhao, Shenmiao Yang, Feifei Tang, Wenjing Yu, Ting Zhao, Xiaohong Liu, Jinsong Jia, Wenbing Duan, Lijuan Hu, Jing Wang, Yang Liu, Nan Peng, Xuelin Dou, Rui Ma, Qiang Fu, Huifang Wang, Kaiyan Liu, Xiaojun
British Journal of Haematology.2023; 202(1): 31. CrossRef
The association mental health of adolescents with economic impact during the COVID-19 pandemic: a 2020 Korean nationally representative survey
Hanul Park, Kang-Sook Lee
BMC Public Health.2023;[Epub] CrossRef
Efficacy and safety of paxlovid (nirmatrelvir/ritonavir) in the treatment of COVID‐19: An updated meta‐analysis and trial sequential analysis
Haokun Tian, Changsen Yang, Tiangang Song, Kechen Zhou, Lequan Wen, Ye Tian, Lirui Tang, Weikai Xu, Xinyuan Zhang
Reviews in Medical Virology.2023;[Epub] CrossRef
Real-World Effectiveness of Nirmatrelvir-Ritonavir and Its Acceptability in High-Risk COVID-19 Patients
Min-Kyung Kim, Kyung-Shin Lee, Sin Young Ham, Youn Young Choi, Eunyoung Lee, Seungjae Lee, Bora Lee, Jaehyun Jeon, BumSik Chin, Yeonjae Kim, Gayeon Kim, Hee-Chang Jang, Jae-Phil Choi, Sang-Won Park
Journal of Korean Medical Science.2023;[Epub] CrossRef
Effectiveness of Molnupiravir Treatment in Patients with COVID-19 in Korea: A Propensity Score Matched Study
Hye Rim Park, Min-Gyu Yoo, Jong Mu Kim, Soon Jong Bae, Hyungmin Lee, Jungyeon Kim
Infection & Chemotherapy.2023; 55(4): 490. CrossRef
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19
Stefanie Reis, Maria-Inti Metzendorf, Rebecca Kuehn, Maria Popp, Ildiko Gagyor, Peter Kranke, Patrick Meybohm, Nicole Skoetz, Stephanie Weibel
Cochrane Database of Systematic Reviews.2023;[Epub] CrossRef

Safety monitoring of COVID-19 vaccination among adolescents aged 12 to 17 years old in the Republic of Korea: Seontae Kim, Insob Hwang, Mijeong Ko, Yunhyung Kwon, Yeon-Kyeng Lee; Osong Public Health Res Perspect. 2022;13(3):230-237. Published online June 10, 2022; DOI: https://doi.org/10.24171/j.phrp.2022.0122

4,953 View
147 Download
9 Web of Science
10 Crossref

Graphical Abstract Abstract PDF

Objectives
This study aimed to disseminate information on coronavirus disease 2019 (COVID-19) vaccine safety among adolescents aged 12 to 17 years in the Republic of Korea. Methods: Two databases were used to assess COVID-19 vaccine safety in adolescents aged 12 to 17 years who completed the primary Pfizer-BioNTech vaccination series. Adverse events reported to the web-based COVID-19 vaccination management system (CVMS) and collected in the text message-based system were analyzed. Results: From March 5, 2021 to February 13, 2022, 12,216 adverse events among 12- to 17-yearolds were reported to the CVMS, of which 97.1% were non-serious adverse events and 2.9% were serious adverse events, including 85 suspected cases of anaphylaxis, 74 suspected cases of myocarditis and/or pericarditis, and 2 deaths. From December 13, 2021 to January 26, 2022, 10,389 adolescents responded to a text message survey, and local/systemic adverse events were more common after dose 2 than after dose 1. The most commonly reported events following either vaccine dose were pain at the injection site, headache, fatigue/tiredness, and myalgia. Conclusion: The overall results are consistent with previous findings; the great majority of adverse events were non-serious, and serious adverse events were rare among adolescents aged 12 to 17 years following Pfizer-BioNTech COVID-19 vaccination.

Citations

Citations to this article as recorded by

Suspected Myocarditis after mRNA COVID-19 Vaccination among South Korean Adolescents
Mi Jin Kim, Jin Hee Kim, Hyun Ok Jun, Kyung Min Kim, Min Sub Jeung, Jun Sung Park
Journal of Pediatric Infectious Diseases.2024; 19(02): 075. CrossRef
Characterization of Brighton Collaboration criteria for myocarditis and pericarditis following COVID-19 vaccine in Korean adolescents
Jue Seong Lee, HyoSug Choi, Seung Hwan Shin, Myung-Jae Hwang, Sara Na, Jong Hee Kim, Sangshin Park, Yoonsun Yoon, Hyun Mi Kang, Bin Ahn, Kyoungsan Seo, Young June Choe
Vaccine.2024; 42(14): 3333. CrossRef
Myopericarditis following COVID-19 vaccination in children: a systematic review and meta-analysis
Ashiley Annushri Thenpandiyan, Ryan Ruiyang Ling, Robert Grignani, Megan Ruien Ling, Arthena Anushka Thenpandiyan, Bee Choo Tai, Jyoti Somani, Kollengode Ramanathan, Swee Chye Quek
Singapore Medical Journal.2024;[Epub] CrossRef
Comparative safety of monovalent and bivalent mRNA COVID-19 booster vaccines in adolescents aged 12 to 17 years in the Republic of Korea
Mijeong Ko, Seontae Kim, Seok-Kyoung Choi, Seung Hwan Shin, Yeon-Kyeng Lee, Yunhyung Kwon
Osong Public Health and Research Perspectives.2024; 15(4): 364. CrossRef
Association of new onset seizure and COVID‐19 vaccines and long‐term follow‐up: A systematic review and meta‐analysis
Ali Rafati, Melika Jameie, Mobina Amanollahi, Yeganeh Pasebani, Nastaran Salimi, Mohammad Hosein Feyz Kazemi, Mana Jameie, Mohammad Yazdan Pasebani, Delaram Sakhaei, Fateme Feizollahi, Churl‐Su Kwon
Epilepsia.2024;[Epub] CrossRef
Immunogenicity, effectiveness, and safety of COVID-19 vaccines among children and adolescents aged 2–18 years: an updated systematic review and meta-analysis
Peng Gao, Liang-Yu Kang, Jue Liu, Min Liu
World Journal of Pediatrics.2023; 19(11): 1041. CrossRef
Incidence of myopericarditis after mRNA COVID-19 vaccination: A meta-analysis with focus on adolescents aged 12–17 years
Bao-Qiang Guo, Hong-Bin Li, Li-Qiang Yang
Vaccine.2023; 41(28): 4067. CrossRef
Safety monitoring of COVID-19 vaccines: February 26, 2021, To June 4, 2022, Republic of Korea
Yeon-Kyeng Lee, Yunhyung Kwon, Yesul Heo, Eun Kyoung Kim, Seung Yun Kim, Hoon Cho, Seontae Kim, Mijeong Ko, Dosang Lim, Soon-Young Seo, Enhi Cho
Clinical and Experimental Pediatrics.2023; 66(10): 415. CrossRef
Risk of Coronavirus Disease 2019 Messenger RNA Vaccination-Associated Myocarditis and Pericarditis – A Systematic Review of Population-Based Data
Yen-Ching Lin, Chia-Hsuin Chang, Wei-Ju Su, Chin-Hui Yang, Jann-Tay Wang
Risk Management and Healthcare Policy.2023; Volume 16: 2085. CrossRef
COVID-19 Vaccination in Korea: Past, Present, and the Way Forward
Eliel Nham, Joon Young Song, Ji Yun Noh, Hee Jin Cheong, Woo Joo Kim
Journal of Korean Medical Science.2022;[Epub] CrossRef

Brief Report

Isolation and identification of monkeypox virus MPXV-ROK-P1-2022 from the first case in the Republic of Korea: Jin-Won Kim, Minji Lee, Hwachul Shin, Chi-Hwan Choi, Myung-Min Choi, Jee Woong Kim, Hwajung Yi, Cheon-Kwon Yoo, Gi-Eun Rhie; Osong Public Health Res Perspect. 2022;13(4):308-311. Published online August 31, 2022; DOI: https://doi.org/10.24171/j.phrp.2022.0232

7,768 View
170 Download
9 Web of Science
9 Crossref

Graphical Abstract Abstract PDF

Objectives
Monkeypox outbreaks in nonendemic countries have been reported since early May 2022. The first case of monkeypox in the Republic of Korea was confirmed in a patient who traveled to Europe in June 2022, and an attempt was made to isolate and identify the monkeypox virus (MPXV) from the patient’s specimens.
Methods
Clinical specimens from the patient were inoculated in Vero E6 cells. The isolated virus was identified as MPXV by the observation of cytopathic effects on Vero E6 cells, transmission electron microscopy, conventional polymerase chain reaction (PCR), and sequencing of PCR products.
Results
Cytopathic effects were observed in Vero E6 cells that were inoculated with skin lesion swab eluates. After multiple passages from the primary culture, orthopoxvirus morphology was observed using transmission electron microscopy. In addition, both MPXV-specific (F3L and ATI) and orthopoxvirus-specific genes (A39R, B2R, and HA) were confirmed by conventional PCR and Sanger sequencing.
Conclusion
These results indicate the successful isolation and identification of MPXV from the first patient in the Republic of Korea. The isolated virus was named MPXV-ROK-P1-2022.

Citations

Citations to this article as recorded by

Ultrasensitive one-pot detection of monkeypox virus with RPA and CRISPR in a sucrose-aided multiphase aqueous system
Yue Wang, Yixin Tang, Yukang Chen, Guangxi Yu, Xue Zhang, Lihong Yang, Chenjie Zhao, Pei Wang, Song Gao, Frederick S. B. Kibenge, Ruijie Deng, Wei Chen, Shuang Yang
Microbiology Spectrum.2024;[Epub] CrossRef
Molecular Methods for Diagnosis of Monkeypox: A Mini-review
Rodrigo Michelini de Oliveira Thomasi, Thais da Silva Correa, Dalise Silva do Carmo, Déborah Fernandes Rodrigues, Luiz Vinicius da Silva Correa, Sandra Rodrigues Xavier, Líria Souza Silva, Jonatas Oliveira da Silva, Michelli dos Santos, Alessandra da Silv
Current Molecular Medicine.2024; 24(10): 1208. CrossRef
Epidemiological, Clinical, and Virological Investigation of the First Four Cases of Monkeypox in Cartagena during the 2022 Outbreak
Steev Loyola, Mashiel Fernández-Ruiz, Doris Gómez-Camargo
Pathogens.2023; 12(2): 159. CrossRef
원숭이두창바이러스의 분리 배양과 전장유전체 정보 분석
민지 이, 진원 김, 치환 최, 화철 신, 명민 최, 상은 이, 화중 이, 윤석 정
Public Health Weekly Report.2023; 16(15): 464. CrossRef
Overview of Diagnostic Methods, Disease Prevalence and Transmission of Mpox (Formerly Monkeypox) in Humans and Animal Reservoirs
Ravendra P. Chauhan, Ronen Fogel, Janice Limson
Microorganisms.2023; 11(5): 1186. CrossRef
How to cope with suspected mpox patients in the outpatient clinic
Nam Joong Kim, Sun Huh
Journal of the Korean Medical Association.2023; 66(5): 325. CrossRef
An Updated Review on Monkeypox Viral Disease: Emphasis on Genomic Diversity
Ali Rabaan, Nada Alasiri, Mohammed Aljeldah, Abeer Alshukairiis, Zainab AlMusa, Wadha Alfouzan, Abdulmonem Abuzaid, Aref Alamri, Hani Al-Afghani, Nadira Al-baghli, Nawal Alqahtani, Nadia Al-baghli, Mashahed Almoutawa, Maha Mahmoud Alawi, Mohammed Alabdull
Biomedicines.2023; 11(7): 1832. CrossRef
Monkeypox (Mpox) virus isolation and ultrastructural characterisation from a Brazilian human sample case
Milene Dias Miranda, Gabriela Cardoso Caldas, Vivian Neuza Ferreira, Ortrud Monika Barth, Aline de Paula Dias da Silva, Mayara Secco Torres Silva, Beatriz Grinsztejn, Valdiléa Gonçalves Veloso, Thiago Moreno Souza, Edson Elias da Silva, Debora Ferreira Ba
Memórias do Instituto Oswaldo Cruz.2023;[Epub] CrossRef
Isolation and Characterization of Monkeypox Virus from the First Case of Monkeypox — Chongqing Municipality, China, 2022
Baoying Huang, Hua Zhao, Jingdong Song, Li Zhao, Yao Deng, Wen Wang, Roujian Lu, Wenling Wang, Jiao Ren, Fei Ye, Houwen Tian, Guizhen Wu, Hua Ling, Wenjie Tan
China CDC Weekly.2022; 4(46): 1019. CrossRef

Review Article

Carbapenem resistance in critically important human pathogens isolated from companion animals: a systematic literature review: Angie Alexandra Rincón-Real, Martha Cecilia Suárez-Alfonso; Osong Public Health Res Perspect. 2022;13(6):407-423. Published online December 16, 2022; DOI: https://doi.org/10.24171/j.phrp.2022.0033

3,985 View
166 Download
7 Web of Science
8 Crossref

Abstract PDF

This study aimed to describe the presence and geographical distribution of Gram-negativebacteria considered critical on the priority list of antibiotic-resistant pathogens publishedby the World Health Organization, including carbapenem-resistant Enterobacteriaceae,carbapenem-resistant Acinetobacter spp., and carbapenem-resistant Pseudomonas aeruginosa.A systematic review of original studies published in 5 databases between 2010 and 2021 wasconducted, including genotypically confirmed carbapenem-resistant isolates obtained fromcanines, felines, and their settings. Fifty-one articles met the search criteria. Carbapenemresistant isolates were found in domestic canines and felines, pet food, and on veterinarymedical and household surfaces. The review found that the so-called “big five”—that is, the5 major carbapenemases identified worldwide in Enterobacterales (New Delhi metallo-βlactamase, active-on-imipenem, Verona integron-encoded metallo-β-lactamase, Klebsiellapneumoniae carbapenemase, and oxacillin [OXA]-48-like)—and the 3 most importantcarbapenemases from Acinetobacter spp. (OXA-23-like, OXA-40-like, and OXA-58-like) hadbeen detected in 8 species in the Enterobacteriaceae family and 5 species of glucose nonfermenting bacilli on 5 continents. Two publications used molecular analysis to confirmcarbapenem-resistant bacteria transmission between owners and dogs. Isolating criticallyimportant human carbapenem-resistant Gram-negative bacteria from domestic canines andfelines highlights the importance of including these animal species in surveillance programsand antimicrobial resistance containment plans as part of the One Health approach.

Citations

Citations to this article as recorded by

First report of a blaNDM-5-carrying Escherichia coli sequence type 12 isolated from a dog with pyometra in Japan
Kazuki Harada, Tadashi Miyamoto, Michiyo Sugiyama, Tetsuo Asai
Journal of Infection and Chemotherapy.2024; 30(9): 938. CrossRef
The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2021–2022

EFSA Journal.2024;[Epub] CrossRef
Epidemiological analysis and prevention strategies in response to a shigellosis cluster outbreak: a retrospective case series in an alternative school in the Republic of Korea, 2023
Yeongseo Ahn, Sunmi Jin, Gemma Park, Hye Young Lee, Hyungyong Lee, Eunkyung Shin, Junyoung Kim, Jaeil Yoo, Yuna Kim
Osong Public Health and Research Perspectives.2024; 15(1): 68. CrossRef
Carbapenem Resistance in Animal-Environment-Food from Africa: A Systematic Review, Recommendations and Perspectives
Komla Dossouvi, Ayawovi Selom Ametepe
Infection and Drug Resistance.2024; Volume 17: 1699. CrossRef
Identification of blaOXA-23 gene in resistant Pseudomonas aeruginosa strains isolated from cows and humans in Basra province, Iraq
Alyaa Sabti Jasim, Abeer Laily Mohammed, Wameedh Hashim Abbas, Hanaa Khaleel Ibraheim, Hasanain A.J. Gharban
Veterinary World.2024; : 1629. CrossRef
The European Union Summary Report on Antimicrobial Resistance in zoonotic and indicator bacteria from humans, animals and food in 2020/2021

EFSA Journal.2023;[Epub] CrossRef
Resistome-based surveillance identifies ESKAPE pathogens as the predominant gram-negative organisms circulating in veterinary hospitals
Flavia Zendri, Cajsa M. Isgren, Jane Devaney, Vanessa Schmidt, Rachel Rankin, Dorina Timofte
Frontiers in Microbiology.2023;[Epub] CrossRef
Unveiling the emergence of multidrug-resistant pathogens in exotic pets from France: a comprehensive study (2017-2019)
Sandro Cardoso, Aurélie Le Loc’h, Inês Marques, Anabela Almeida, Sérgio Sousa, Maria José Saavedra, Sofia Anastácio, Eduarda Silveira
One Health & Implementation Research.2023; 3(4): 161. CrossRef

Short Communication

COVID-19 outbreak and risk factors for infection in a taekwondo gym in the Republic of Korea: Seung Hwan Shin, Eonjoo Park, Sookhyun Kim, Minji Jang, Subin Park, Dong-Hwi Kim, Tae Jong Son, Ji-Hyuk Park; Osong Public Health Res Perspect. 2022;13(2):162-170. Published online March 31, 2022; DOI: https://doi.org/10.24171/j.phrp.2021.0295

5,100 View
119 Download
8 Web of Science
8 Crossref

Abstract PDF

Objectives
Relatively few studies have assessed risk factors for coronavirus disease 2019 (COVID-19) in public facilities used by children and adolescents. This study presents an analysis of a COVID-19 outbreak that occurred in a taekwondo gym in Korea, predominantly among children and adolescents, with the aim of providing insights on managing COVID-19 outbreaks in similar facilities. Methods: All 108 taekwondo gym students and staff received COVID-19 tests. A survey and closed-circuit television analyses were used to identify risk factors. A univariate analysis was conducted, followed by multivariate logistic regression analysis with backward elimination for variables with a significance level <0.10 in the univariate analysis. Results: COVID-19 was confirmed in 30 of 108 subjects at the taekwondo gym (attack rate, 27.8%). The outbreak started in an adult class student. This student transmitted the virus to the staff, who consequently transmitted the virus to adolescent students. In the univariate analysis, the relative risk for younger age (≤9 years) was 2.14 (95% confidence interval [CI], 1.01–4.54; p=0.054), and that for food consumption inside the gym was 2.12 (95% CI, 1.04–4.30; p=0.048). In the multivariate logistic regression analysis, the odds ratio for younger age was 2.96 (95% CI, 1.07–8.20; p=0.036), and that for food consumption inside the gym was 3.00 (95% CI, 1.10–8.17; p=0.032). Conclusion: Food consumption inside the facility and young age were significant risk factors for COVID-19 transmission in this taekwondo gym. Food consumption should be prohibited in sports facilities, and infection prevention education for young students is also required.

Citations

Citations to this article as recorded by

The First Outbreak of Novel Coronavirus Disease 2019 (COVID-19) at an Outdoor Camping Site in South Korea, 2020
Na-Young Kim, Seonhee Ahn, GwangJin Kim, Donghyok Kwon, Young-Joon Park, Sang-Eun Lee
Journal of Epidemiology.2024; 34(4): 203. CrossRef
Risk evaluation of venue types and human behaviors of COVID-19 outbreaks in public indoor environments: A systematic review and meta-analysis
Weiwei Huang, Caroline X. Gao, Danting Luo, Yong Wang, Xiaohong Zheng, Cong Liu, Ying Wang, Yuguo Li, Hua Qian
Environmental Pollution.2024; 341: 122970. CrossRef
Investigating Factors Contributing to the Occurrence of COVID-19 Outbreaks in Athletes in a Scoping Review
Shuichi KASAMA, Haruyo SAKAKI, Eiko ENDO
Taiikugaku kenkyu (Japan Journal of Physical Educa.2024; 69: 151. CrossRef
The Risk of SARS-CoV-2 Transmission in Community Indoor Settings: A Systematic Review and Meta-analysis
Mark Rohit Francis, Saheed Gidado, J Pekka Nuorti
The Journal of Infectious Diseases.2024;[Epub] CrossRef
Identifying risk factors for COVID-19 cluster infections in schools in the Republic of Korea: a case-control study
Jihyun Choi, Seongju Choi, Baigu Lee, Young-Joon Park, Sang Eun Lee
Osong Public Health and Research Perspectives.2024; 15(4): 375. CrossRef
SARS-CoV-2 transmission modes: Why and how contamination occurs around shared meals and drinks?
Aure Saulnier, Jean-Michel Wendling, Benoit Hermant, Didier Lepelletier
Food Microbiology.2023; 114: 104297. CrossRef
Risk factors for COVID-19 outbreaks in livestock slaughtering and processing facilities in Republic of Korea
Seongju Choi, Tae Jong Son, Yeon-Kyung Lee
Osong Public Health and Research Perspectives.2023; 14(3): 207. CrossRef
Protective facemask-induced facial thermal stress and breathing burden during exercise in gyms
Qilong Zhong, Jiyun Song, Dachuan Shi, Chung-Hin Dung
Building and Environment.2023; 244: 110840. CrossRef

Original Articles

The role of risk perception, risk communication, and demographic factors in COVID-19 preventive behaviors: an online survey in Iran: Mansour Rezaei, Nader Rajabi Gilan, Ali Almasi, Mehdi Khezeli, Fatemeh Jamshidi Nazar, Zahra Jorjoran Shushtari, Yahya Salimi, Farid Najafi, Neda Sarabi, Shahram Saeidi, Saeid Saeidi; Osong Public Health Res Perspect. 2022;13(4):282-289. Published online August 31, 2022; DOI: https://doi.org/10.24171/j.phrp.2021.0345

3,861 View
66 Download
6 Web of Science
7 Crossref

Abstract PDF

Objectives
This study investigated preventive behaviors toward coronavirus disease 2019 (COVID-19) and related factors in a Kurdish Iranian sample.
Methods
This online survey was conducted among the population aged 18 and above in Kermanshah Province, in western Iran, in April 2020. Samples were invited and recruited through social media. Data were collected using a questionnaire consisting of 4 sections (questions on demographic variables, risk perception, risk communication, and COVID-19 preventive behaviors) and analyzed using Stata ver. 8.
Results
The Pearson correlation test showed that risk communication was significantly correlated with COVID-19 preventive behaviors (r=0.320, p<0.01). In the final model, where the explanatory power increased with the entry of the risk communication variable, the variables explained a total of 14% of variance in COVID-19 preventive behaviors. Sex (β=−0.482), risk perception (β=0.047), and risk communication (β=0.662) were significant determinants.
Conclusion
Risk communication and risk perception related to COVID-19, as well as being a woman, were determinants of COVID-19 preventive behaviors.

Citations

Citations to this article as recorded by

Predisposing factors of using cosmetics in Iranian female students: application of prototype willingness model
Shandiz Moslehi, Asghar Tavan, Sajjad Narimani, Fatemeh Ahmadi, Masoomeh Kazemzadeh, Nadia Sedri
Frontiers in Psychology.2024;[Epub] CrossRef
Utilizing social media for community risk communication in megacities: analysing the impact of WeChat group information interaction and perception on communication satisfaction during the COVID-19 pandemic in Shanghai
Yasai Chen, Yiru Chen, Shan Yu, Shuni Yu
BMC Public Health.2024;[Epub] CrossRef
The strongest predictors of compliance with health protocols among marketers and guilds based on the transtheoretical model
Shandiz Moslehi, Asghar Tavan, Sajjad Narimani, Fardin shahbazzadeh, Nadia Sedri, Sama Sabahi
BMC Public Health.2024;[Epub] CrossRef
Adaptive measures to deal with the next pandemic caused by climate change in at-risk groups
Laleh Hassani, Reihaneh Taheri Kondar, Sajjad Narimani, Amin Ghanbarnejad
BMC Psychiatry.2024;[Epub] CrossRef
Understanding Australian Government Risk Communication Early in the COVID-19 Pandemic: Sociodemographics, Risk Attitudes and Media Consumption
Yiyun Shou, Louise M. Farrer, Amelia Gulliver, Eryn Newman, Philip J. Batterham, Michael Smithson
Journal of Health Communication.2023; 28(4): 254. CrossRef
Risk perception and avoidance of preventive behavior on the COVID‐19 among cancer patients
Mehdi Khezeli, Asghar Tavan, Sajjad Narimani, Vahideh Hoseini, Elham Zare Hosseinzadeh, Parisa Motamedi
Health Science Reports.2023;[Epub] CrossRef
The Role of Risk Communication in Shaping Health-Protective Behavior Amid the COVID-19 Pandemic in Thailand
Suphunnika Termmee, Bing Wang
Social Sciences.2023; 12(10): 551. CrossRef

Menstrual hygiene management and its determinants among adolescent girls in low-income urban areas of Delhi, India: a community-based study: Suneela Garg, Nidhi Bhatnagar, Mongjam Meghachandra Singh, Saurav Basu, Amod Borle, Yamini Marimuthu, Falak Azmi, Yomri Dabi, Indu Bala; Osong Public Health Res Perspect. 2022;13(4):273-281. Published online August 31, 2022; DOI: https://doi.org/10.24171/j.phrp.2022.0127

4,836 View
311 Download
5 Web of Science
6 Crossref

Abstract PDF

Objectives
Menstrual hygiene management (MHM) in developing countries is linked to human rights, social justice, and the education and empowerment of young girls. The objective of this study was to assess menstrual hygiene practices and their determinants among adolescent girls, including school dropouts, and the effects of pad distribution programs in urban resettlement areas of Delhi, India.
Methods
A cross-sectional study was conducted from March 2019 to February 2020 in urban resettlement colonies and 2 villages of Delhi among 1,130 adolescent girls aged 10 to 19 years, who were interviewed face to face.
Results
In total, 954 participants (84.4%) used only disposable sanitary pads, 150 (13.3%) used both sanitary pads and cloths, and 26 (2.3%) used only cloths (n=1,130). Most school-going girls utilized the scheme for pad distribution, but only two-thirds of the girls who were out of school utilized the scheme. In the adjusted analysis, girls with lower educational status, those who had dropped out of school, and those from the Muslim religious community were more likely to use cloths for MHM.
Conclusion
More than 4 out of 5 adolescent girls in Delhi in low-income neighborhoods preferred sanitary pads for MHM. The government free pad scheme reached near-universal utilization among school-going girls (97%), but the subsidized pad scheme for girls who did not attend school was insufficiently utilized (75%).

Citations

Citations to this article as recorded by

Factors Associated with Exclusive Use of Hygienic Methods during Menstruation among Adolescent Girls (15–19 Years) in Urban India: Evidence from NFHS-5
Doli Roy, Nuruzzaman Kasemi, Manik Halder, Malasree Majumder
Heliyon.2024; 10(8): e29731. CrossRef
Enhancement of Health-related Quality of Life among School-going Adolescent Girls with Improvement in Menstrual Hygiene Knowledge and Practices
Akanksha Goyal, Sunita Agarwal
Archives of Medicine and Health Sciences.2024; 12(1): 73. CrossRef
Menstrual practice needs among college going women in Coimbatore district, India: an analytical cross-sectional study
Vijayakumar Ramya, Mohan Kumar, Jeevithan Shanmugam, N. Seetharaman, Sushmitha Mahanshetty, Srihari Dhandapani, P. Aparnavi, Thavansree Durairaj, Ramesh Rathinamoorthy
Discover Public Health.2024;[Epub] CrossRef
Menstrual Hygiene Problems and Challenges Faced by Adolescent Females in Rural Areas: A Narrative Review
Vijiya Kashyap, Sonali G Choudhari
Cureus.2023;[Epub] CrossRef
Perceived difficulties in maintaining menstrual hygiene practices among indigenous adolescents during seasonal water scarcity periods in Bandarban hill district of Bangladesh: A cross-sectional study
Imdadul Haque Talukdar, M.A. Rifat, Plabon Sarkar, Nobonita Saha, Mesfin Kassaye Tessma, Md. Ibrahim Miah
International Journal of Hygiene and Environmental.2023; 254: 114268. CrossRef
Menstrual hygiene practices among adolescent women in rural India: a cross-sectional study
Aditya Singh, Mahashweta Chakrabarty, Shivani Singh, Rakesh Chandra, Sourav Chowdhury, Anshika Singh
BMC Public Health.2022;[Epub] CrossRef

Seroprevalence of immunoglobulin G antibodies against SARS-CoV-2 in children and adolescents in Delhi, India, from January to October 2021: a repeated cross-sectional analysis: Pragya Sharma, Saurav Basu, Suruchi Mishra, Mongjam Meghachandra Singh; Osong Public Health Res Perspect. 2022;13(3):184-190. Published online June 10, 2022; DOI: https://doi.org/10.24171/j.phrp.2022.0014

5,966 View
84 Download
5 Web of Science
6 Crossref

Graphical Abstract Abstract PDF

Objectives
The aim of this study was to assess changes in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) seroprevalence among children and adolescents in Delhi, India from January 2021 to October 2021. Methods: This was a repeated cross-sectional analysis of participants aged 5 to 17 years from 2 SARS-CoV-2 seroprevalence surveys conducted in Delhi, India during January 2021 and September to October 2021. Anti-SARS-CoV-2 IgG antibodies were detected by using the VITROS assay (90% sensitivity, 100% specificity). Results: The seroprevalence among 5- to 17-year-old school-age children and adolescents increased from 52.8% (95% confidence interval [CI], 51.3%−54.3%) in January 2021 to 81.8% (95% CI, 80.9%−82.6%) in September to October 2021. The assay-adjusted seroprevalence was 90.8% (95% CI, 89.8%−91.7%). Seropositivity positively correlated with participants’ age (p<0.001), but not sex (p=0.388). A signal to cut-off ratio ≥4.00, correlating with the presence of neutralization antibodies, was observed in 4,814 (57.9%) participants. Conclusion: The high percentage of seroconversion among children and adolescents indicates the presence of natural infection-induced immunity from past exposure to the SARS-CoV-2 virus. However, the lack of hybrid immunity and the concomitant likelihood of lower levels of neutralization antibodies than in adults due to the absence of vaccination warrants careful monitoring and surveillance of infection risk and disease severity from newer and emergent variants.

Citations

Citations to this article as recorded by

SARS-CoV-2 in Mozambican primary school-aged children at Maputo City and Province: a cross-sectional study from a low-income country
Adilson Fernando Loforte Bauhofer, Édio Ussivane, Assucênio Chissaque, Fátima Iahaia, Ramígio Pololo, Fernanda Campos, Emerson Miranda, Luciana António, Plácida Maholela, Aline Gatambire, Marlene Djedje, Fátima Ráice, Luzia Gonçalves, Nilsa de Deus, Osval
BMC Pediatrics.2024;[Epub] CrossRef
Pediatric antibody responses to SARS-CoV-2 after infection and vaccination in Calgary, Canada
Leah J. Ricketson, Emily J. Doucette, Isabella Alatorre, Tarannum Tarannum, Joslyn Gray, William Booth, Graham Tipples, Carmen Charlton, Jamil N. Kanji, Kevin Fonseca, James D. Kellner
BMC Infectious Diseases.2024;[Epub] CrossRef
Seroprevalence of SARS-CoV-2 IgG antibodies among rural children aged 6-14 years in a selected block of West Bengal, India
Vineeta Shukla, Vivek Shukla, Mausumi Basu, Aparajita Mondal, Mamunur Rashid, Ripan Saha
IMC Journal of Medical Science.2024; : 1. CrossRef
Severe Acute Hepatitis of Unknown Etiology Presenting as Pediatric Acute Liver Failure: Analysis of Likely Etiology, Clinical Course and Outcome
Bikrant B. Lal, Vikrant Sood, Ekta Gupta, Reshu Agarwal, Rajeev Khanna, Seema Alam
Journal of Clinical and Experimental Hepatology.2023; 13(5): 912. CrossRef
Anti-SARS-CoV-2 antibody kinetics up to 6 months of follow-up: Result from a nation-wide population-based, age stratified sero-epidemiological prospective cohort study in India
Puneet Misra, Arvind Kumar Singh, Baijayantimala Mishra, Bijayini Behera, Binod Kumar Patro, Guruprasad R. Medigeshi, Hari Shanker Joshi, Mohammad Ahmad, Pradeep Kumar Chaturvedi, Palanivel Chinnakali, Partha Haldar, Mohan Bairwa, Pradeep Kharya, Rahul Dh
PLOS ONE.2023; 18(12): e0287807. CrossRef
Seroprevalence of SARS CoV-2 among children after the second surge (June 2021) in a rural district of South India: Findings and lessons from a population-based survey
Carolin Elizabeth George, Leeberk Raja Inbaraj, Shon Rajukutty, Roshni Florina Joan, Sangeetha Muthuraj, Sindhulina Chandrasingh
Frontiers in Pediatrics.2022;[Epub] CrossRef

Review Article

Strategies to combat Gram-negative bacterial resistance to conventional antibacterial drugs: a review: Priyanka Bhowmik, Barkha Modi, Parijat Roy, Antarika Chowdhury; Osong Public Health Res Perspect. 2023;14(5):333-346. Published online October 18, 2023; DOI: https://doi.org/10.24171/j.phrp.2022.0323

3,812 View
251 Download
5 Web of Science
5 Crossref

Graphical Abstract Abstract PDF

The emergence of antimicrobial resistance raises the fear of untreatable diseases. Antimicrobial resistance is a multifaceted and dynamic phenomenon that is the cumulative result of different factors. While Gram-positive pathogens, such as methicillin-resistant Staphylococcus aureus and Clostridium difficile, were previously the most concerning issues in the field of public health, Gram-negative pathogens are now of prime importance. The World Health Organization’s priority list of pathogens mostly includes multidrug-resistant Gram-negative organisms particularly carbapenem-resistant Enterobacterales, carbapenem-resistant Pseudomonas aeruginosa, and extensively drug-resistant Acinetobacter baumannii. The spread of Gram-negative bacterial resistance is a global issue, involving a variety of mechanisms. Several strategies have been proposed to control resistant Gram-negative bacteria, such as the development of antimicrobial auxiliary agents and research into chemical compounds with new modes of action. Another emerging trend is the development of naturally derived antibacterial compounds that aim for targets novel areas, including engineered bacteriophages, probiotics, metal-based antibacterial agents, odilorhabdins, quorum sensing inhibitors, and microbiome-modifying agents. This review focuses on the current status of alternative treatment regimens against multidrug-resistant Gram-negative bacteria, aiming to provide a snapshot of the situation and some information on the broader context.

Citations

Citations to this article as recorded by

Efficacy of new generation biosorbents for the sustainable treatment of antibiotic residues and antibiotic resistance genes from polluted waste effluent
Barkha Madhogaria, Sangeeta Banerjee, Atreyee Kundu, Prasanta Dhak
Infectious Medicine.2024; 3(1): 100092. CrossRef
Evaluation of Plant-Based Silver Nanoparticles for Antioxidant Activity and Promising Wound-Healing Applications
Maria Qubtia, Shazia Akram Ghumman, Sobia Noreen, Huma Hameed, Shazia Noureen, Rizwana Kausar, Ali Irfan, Pervaiz Akhtar Shah, Hafsa Afzal, Misbah Hameed, Mohammad Raish, Maria Rana, Ajaz Ahmad, Katarzyna Kotwica-Mojzych, Yousef A. Bin Jardan
ACS Omega.2024; 9(10): 12146. CrossRef
Progress and potentialities in wood extractives-based materials for active food packaging applications
Eliana I. Fernández Sosa, Nanci Ehman, Fernando E. Felissia, M. Guadalupe Chaves, M. Cristina Area
Food Bioscience.2024; 60: 104489. CrossRef
Isolation, derivatization, and anti-microbial evaluation of secondary metabolites from Garcinia dryobalanoides
Nur Fazlin Zafirah Zaine, Nor Hisam Zamakshshari, Ainaa Nadiah Abd Halim, Vivien Jong Yi Mian, Ngieng Ngui Sing
Natural Product Research.2024; : 1. CrossRef
A comprehensive investigation of the anion inhibition profile of a β-carbonic anhydrase from Acinetobacter baumannii for crafting innovative antimicrobial treatments
Viviana De Luca, Simone Giovannuzzi, Claudiu T. Supuran, Clemente Capasso
Journal of Enzyme Inhibition and Medicinal Chemist.2024;[Epub] CrossRef

Special Article

A framework for nationwide COVID-19 vaccine safety research in the Republic of Korea: the COVID-19 Vaccine Safety Research Committee: Na-Young Jeong, Hyesook Park, Sanghoon Oh, Seung Eun Jung, Dong-Hyun Kim, Hyoung-Shik Shin, Hee Chul Han, Jong-Koo Lee, Jun Hee Woo, Byung-Joo Park, Nam-Kyong Choi; Osong Public Health Res Perspect. 2023;14(1):5-14. Published online February 28, 2023; DOI: https://doi.org/10.24171/j.phrp.2023.0026

3,918 View
169 Download
7 Web of Science
5 Crossref

Graphical Abstract Abstract PDF

With the introduction of coronavirus disease 2019 (COVID-19) vaccines, the Korea Disease Control and Prevention Agency (KDCA) commissioned the National Academy of Medicine of Korea to gather experts to independently assess post-vaccination adverse events. Accordingly, the COVID-19 Vaccine Safety Research Committee (CoVaSC) was launched in November 2021 to perform safety studies and establish evidence for policy guidance. The CoVaSC established 3 committees for epidemiology, clinical research, and communication. The CoVaSC mainly utilizes pseudonymized data linking KDCA’s COVID-19 vaccination data and the National Health Insurance Service’s claims data. The CoVaSC’s 5-step research process involves defining the target diseases and organizing ad-hoc committees, developing research protocols, performing analyses, assessing causal relationships, and announcing research findings and utilizing them to guide compensation policies. As of 2022, the CoVaSC completed this research process for 15 adverse events. The CoVaSC launched the COVID-19 Vaccine Safety Research Center in September 2022 and has been reorganized into 4 divisions to promote research including international collaborative studies, long-/short-term follow-up studies, and education programs. Through these enhancements, the CoVaSC will continue to swiftly provide scientific evidence for COVID-19 vaccine research and compensation and may serve as a model for preparing for future epidemics of new diseases.

Citations

Citations to this article as recorded by

Risk of encephalitis and meningitis after COVID-19 vaccination in South Korea: a self-controlled case series analysis
Ju Hwan Kim, Dongwon Yoon, Hwa Yeon Ko, Kyungyeon Jung, Jun-Sang Sunwoo, Won Chul Shin, Jung-Ick Byun, Ju-Young Shin
BMC Medicine.2024;[Epub] CrossRef
The COVID-19 Vaccine Safety Research Center: a cornerstone for strengthening safety evidence for COVID-19 vaccination in the Republic of Korea
Na-Young Jeong, Hyesook Park, Sanghoon Oh, Seung Eun Jung, Dong-Hyun Kim, Hyoung-Shik Shin, Hee Chul Han, Jong-Koo Lee, Jun Hee Woo, Jaehun Jung, Joongyub Lee, Ju-Young Shin, Sun-Young Jung, Byung-Joo Park, Nam-Kyong Choi
Osong Public Health and Research Perspectives.2024; 15(2): 97. CrossRef
A Causality Assessment Framework for COVID-19 Vaccines and Adverse Events at the COVID-19 Vaccine Safety Research Center
Seyoung Kim, Jeong Ah Kim, Hyesook Park, Sohee Park, Sanghoon Oh, Seung Eun Jung, Hyoung-Shik Shin, Jong Koo Lee, Hee Chul Han, Jun Hee Woo, Byung-Joo Park, Nam-Kyong Choi, Dong-Hyun Kim
Journal of Korean Medical Science.2024;[Epub] CrossRef
To become a more stronger and safer country
Jong-Koo Lee
Osong Public Health and Research Perspectives.2023; 14(2): 67. CrossRef
Risk of lymphadenopathy from SARS-CoV-2 vaccination: a self-controlled case series analysis
Mi-Sook Kim, Bongyoung Kim, Jeong Pil Choi, Nam-Kyong Choi, Jung Yeon Heo, Jun Yong Choi, Joongyub Lee, Sang Il Kim
Epidemiology and Health.2023; : e2023090. CrossRef

Original Article

Associations of pre-existing cardiovascular morbidity with severity and the fatality rate in COVID-19 patients: a systematic review and meta-analysis: Foad Alzoughool, Suhad Abumweis, Lo’ai Alanagreh, Manar Atoum; Osong Public Health Res Perspect. 2022;13(1):37-50. Published online February 18, 2022; DOI: https://doi.org/10.24171/j.phrp.2021.0186

5,171 View
119 Download
5 Web of Science
5 Crossref

Graphical Abstract Abstract PDF Supplementary Material

Objectives
The aim of this study was to evaluate the association of pre-existing cardiovascular comorbidities, including hypertension and coronary heart disease, with coronavirus disease 2019 (COVID-19) severity and mortality. Methods: PubMed, ScienceDirect, and Scopus were searched between January 1, 2020, and July 18, 2020, to identify eligible studies. Random-effect models were used to estimate the pooled event rates of pre-existing cardiovascular disease comorbidities and odds ratio (OR) with 95% confidence intervals (95% CIs) of disease severity and mortality associated with the exposures of interest. Results: A total of 34 studies involving 19,156 patients with COVID-19 infection met the inclusion criteria. The prevalence of pre-existing cardiovascular disease in the included studies was 14.0%. Pre-existing cardiovascular disease in COVID-19 patients was associated with severe outcomes (OR, 4.1; 95% CI, 2.9 to 5.7) and mortality (OR, 6.1; 95% CI, 2.9 to 12.7). Hypertension and coronary heart disease increased the risk of severe outcomes by 2.6 times (OR, 2.6; 95% CI, 1.9 to 3.6) and 2.5 times (OR, 2.5; 95% CI, 1.7 to 3.8), respectively. No significant publication bias was indicated. Conclusion: COVID-19 patients with pre-existing cardiovascular comorbidities have a higher risk of severe outcomes and mortality. Awareness of pre-existing cardiovascular comorbidity is important for the early management of COVID-19.

Citations

Citations to this article as recorded by

Asthma and clinical outcomes of COVID-19 in a community setting
L. Jiao, D. Bujnowski, P. Liu, E. Bakota, L. Liu, Y. Ye, A. Dewangan, C.N. Duong, E. Kviten, S. Zaheer, A. Zangeneh, R. Roy, J. Floyd, J. Monroy, D. Wiltz-Beckham
Public Health.2024; 226: 84. CrossRef
Understanding factors affecting implementation success and sustainability of a comprehensive prevention program for cardiovascular disease in primary health care: a qualitative process evaluation study combining RE-AIM and CFIR
Naomi Aerts, Kathleen Van Royen, Peter Van Bogaert, Lieve Peremans, Hilde Bastiaens
Primary Health Care Research & Development.2023;[Epub] CrossRef
New Scenarios in Heart Transplantation and Persistency of SARS-CoV-2 (Case Report)
Lubov Mitrofanova, Igor Makarov, Andrey Gorshkov, Olga Vorobeva, Maria Simonenko, Anna Starshinova, Dmitry Kudlay, Tatiana Karonova
Life.2023; 13(7): 1551. CrossRef
Prognostic Factors of COVID‐19: An Umbrella Review Endorsed by the International Society for Pharmacoepidemiology
Grammati Sarri, Wei Liu, Luke Zabotka, Andreas Freitag, Ravinder Claire, Grace Wangge, Jamie Elvidge, Dalia Dawoud, Dimitri Bennett, Xuerong Wen, Xiaojuan Li, Christopher T. Rentsch, Md Jamal Uddin, M. Sanni Ali, Mugdha Gokhale, Anouk Déruaz‐Luyet, Daniel
Clinical Pharmacology & Therapeutics.2023; 114(3): 604. CrossRef
Comorbidities in congenital heart disease: different patterns in childhood and adulthood
Zhibao Ding, Jingai Zhu, Ye Ding, Chun Zhu
BMC Cardiovascular Disorders.2023;[Epub] CrossRef

Short Communication

Epidemiological characteristics of carbapenemase-producing Enterobacteriaceae outbreaks in the Republic of Korea between 2017 and 2022: Hyoseon Jeong, Junghee Hyun, Yeon-Kyeng Lee; Osong Public Health Res Perspect. 2023;14(4):312-320. Published online August 21, 2023; DOI: https://doi.org/10.24171/j.phrp.2023.0069

2,001 View
167 Download
4 Web of Science
4 Crossref

Graphical Abstract Abstract PDF

Objectives
We aimed to describe the epidemiological characteristics of carbapenemase-producing Enterobacteriaceae (CPE) outbreaks in healthcare settings in the Republic of Korea between 2017 and 2022.
Methods
Under the national notifiable disease surveillance system, we obtained annual descriptive statistics regarding the isolated species, carbapenemase genotype, healthcare facility type, outbreak location and duration, and number of patients affected and recommended interventions. We used epidemiological investigation reports on CPE outbreaks reported to Korea Disease Control and Prevention Agency from June 2017 to September 2022.
Results
Among the 168 reports analyzed, Klebsiella pneumoniae (85.1%) was the most frequently reported species, while K. pneumoniae carbapenemase (KPC, 82.7%) was the most common carbapenemase genotype. Both categories increased from 2017 to 2022 (p<0.01). General hospitals had the highest proportion (54.8%), while tertiary general hospitals demonstrated a decreasing trend (p<0.01). The largest proportion of outbreaks occurred exclusively in intensive care units (ICUs, 44.0%), and the frequency of concurrent outbreaks in ICUs and general wards increased over time (p<0.01). The median outbreak duration rose from 43.5 days before the coronavirus disease 2019 (COVID-19) pandemic (2017–2019) to 79.5 days during the pandemic (2020–2022) (p=0.01), and the median number of patients associated with each outbreak increased from 5.0 to 6.0 (p=0.03). Frequently recommended interventions included employee education (38.1%), and 3 or more measures were proposed for 45.2% of outbreaks.
Conclusion
In the Republic of Korea, CPE outbreaks have been consistently dominated by K. pneumoniae and KPC. The size of these outbreaks increased during the COVID-19 pandemic. Our findings highlight the need for continuing efforts to control CPE outbreaks using a multimodal approach, while considering their epidemiology.

Citations

Citations to this article as recorded by

Comparison of clinical outcomes of patients with serial negative surveillance cultures according to a subsequent polymerase chain reaction test for carbapenemase-producing Enterobacterales
H. Seo, S. Kim, Y.W. Lee, H.S. Oh, H-S. Kim, Y.K. Kim
Journal of Hospital Infection.2024; 146: 93. CrossRef
Identifying Contact Time Required for Secondary Transmission of Clostridioides difficile Infections by Using Real-Time Locating System
Min Hyung Kim, Jaewoong Kim, Heejin Ra, Sooyeon Jeong, Yoon Soo Park, Dongju Won, Hyukmin Lee, Heejung Kim
Emerging Infectious Diseases.2024;[Epub] CrossRef
Antimicrobial activity of ceftazidime-avibactam against KPC-2-producing Enterobacterales: a cross-combination and dose-escalation titration study with relebactam and vaborbactam
Min Seo Kang, Jin Yang Baek, Jae-Hoon Ko, Sun Young Cho, Keon Young Lee, Young Ho Lee, Jinyoung Yang, Tae Yeul Kim, Hee Jae Huh, Nam Yong Lee, Kyungmin Huh, Cheol-In Kang, Doo Ryeon Chung, Kyong Ran Peck, Bobby G. Warren
Microbiology Spectrum.2024;[Epub] CrossRef
Performance comparison of BD Phoenix CPO detect panel with Cepheid Xpert Carba-R assay for the detection of carbapenemase-producing Klebsiella pneumoniae isolates
Nazmiye Ülkü Tüzemen, Uğur Önal, Osman Merdan, Bekir Akca, Beyza Ener, Halis Akalın, Cüneyt Özakın
BMC Microbiology.2024;[Epub] CrossRef

Brief Report

Presumed population immunity to SARS-CoV-2 in South Korea, April 2022: Eun Jung Jang, Young June Choe, Seung Ah Choe, Yoo-Yeon Kim, Ryu Kyung Kim, Jia Kim, Do Sang Lim, Ju Hee Lee, Seonju Yi, Sangwon Lee, Young-Joon Park; Osong Public Health Res Perspect. 2022;13(5):377-381. Published online October 14, 2022; DOI: https://doi.org/10.24171/j.phrp.2022.0209

2,906 View
77 Download
3 Web of Science
4 Crossref

Graphical Abstract Abstract PDF

Objectives
We estimated the overall and age-specific percentages of the Korean population with presumed immunity against severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) as of April 2022 using the national registry.
Methods
We used the national coronavirus disease 2019 (COVID-19) infection and vaccination registry from South Korea, as described to define individuals with a previous history of COVID-19 infection, vaccination, or both, as persons with presumed immunity.
Results
Of a total of 53,304,627 observed persons, 24.4% had vaccination and infection, 58.1% had vaccination and no infection, 7.6% had infection and no vaccination, and 9.9% had no immunity. The SARS-CoV-2 Omicron variant emerged at a time when the presumed population immunity ranged from 80% to 85%; however, nearly half of the children were presumed to have no immunity.
Conclusion
We report a gap in population immunity, with lower presumed protection in children than in adults. The approach presented in this work can provide valuable informed tools to assist vaccine policy-making at a national level.

Citations

Citations to this article as recorded by

Realistic Estimation of COVID-19 Infection by Seroprevalence Surveillance of SARS-CoV-2 Antibodies: An Experience From Korea Metropolitan Area From January to May 2022
In Hwa Jeong, Jong-Hun Kim, Min-Jung Kwon, Jayoung Kim, Hee Jin Huh, Byoungguk Kim, Junewoo Lee, Jeong-hyun Nam, Eun-Suk Kang
Journal of Korean Medical Science.2024;[Epub] CrossRef
Epidemiology of Coronavirus Disease 2019 in Infants and Toddlers, Seoul, South Korea
JiWoo Sim, Euncheol Son, Young June Choe
Pediatric Infection & Vaccine.2024; 31(1): 94. CrossRef
Predicting adherence to COVID-19 preventive measures among South Korean adults aged 40 to 69 Years using the expanded health empowerment model
Su-Jung Nam, Tae-Young Pak
SSM - Population Health.2023; 22: 101411. CrossRef
Acute COVID-19 in unvaccinated children without a history of previous infection during the delta and omicron periods
Jee Min Kim, Ji Yoon Han, Seung Beom Han
Postgraduate Medicine.2023; 135(7): 727. CrossRef

First
Prev
Page of 5
Next
Last

Most cited